scispace - formally typeset
S

Suck Joon Hong

Researcher at University of Ulsan

Publications -  136
Citations -  5404

Suck Joon Hong is an academic researcher from University of Ulsan. The author has contributed to research in topics: Thyroid carcinoma & Thyroid cancer. The author has an hindex of 40, co-authored 132 publications receiving 4774 citations. Previous affiliations of Suck Joon Hong include Asan Medical Center.

Papers
More filters
Journal ArticleDOI

Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings.

TL;DR: Routine use of ultrasound‐guided fine‐needle aspiration (USGFNA) has been the source of much controversy due to the lack of large‐scale studies and lack of data on the natural course of well‐differentiated thyroid cancer of small size.
Journal ArticleDOI

The BRAF mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma

TL;DR: The activating BRAFV600E mutation is the most common genetic alteration reported in papillary thyroid carcinoma (PTC) and is associated with factors predicting a poor prognosis and recurrence.
Journal ArticleDOI

18F‐Fluorodeoxyglucose Uptake in Thyroid from Positron Emission Tomogram (PET) for Evaluation in Cancer Patients: High Prevalence of Malignancy in Thyroid PET Incidentaloma

TL;DR: The prevalence of incidental thyroid 18F‐fluorodeoxyglucose (FDG) uptake in positron emission tomogram (PET) scan for evaluation in cancer patients and the role of standard uptake value (SUV) measurement in differentiation of thyroid malignancy from benign disease are investigated.
Journal ArticleDOI

Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.

TL;DR: Data indicate that serum Tg levels measured at the time of immediate postoperative remnant ablation correlated well with serum TG levels at thetime of the initial diagnostic WBS and had a complementary role for predicting persistence or recurrence of disease in the earliest postoperative period.
Journal ArticleDOI

The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma

TL;DR: This data indicates that the BRAFV600E mutation, the most common genetic alteration reported in papillary thyroid carcinoma, has been associated with poor prognostic factors and should be considered as a predictive factor for further studies.